Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E Dosing for NAFLD
NCT01792115Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- May 2013
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin e in non-alcoholic fatty liver disease (NAFLD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started May 2013; status: completed.
02
Drugs
vitamin e
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01792115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01792115.